Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40.8M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
31.8M
-
Shares change
-
-4.44M
-
Total reported value, excl. options
-
$51.5M
-
Value change
-
-$11.7M
-
Number of buys
-
49
-
Number of sells
-
-55
-
Price
-
$1.62
Significant Holders of Pulmonx Corp - COM (LUNG) as of Q3 2025
129 filings reported holding LUNG - Pulmonx Corp - COM as of Q3 2025.
Pulmonx Corp - COM (LUNG) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.8M shares
of 40.8M outstanding shares and own 78.05% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (4.96M shares), MORGAN STANLEY (3.62M shares), BlackRock, Inc. (2.67M shares), VANGUARD GROUP INC (2.24M shares), FMR LLC (2.17M shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (1.26M shares), DEUTSCHE BANK AG\ (1.13M shares), GEODE CAPITAL MANAGEMENT, LLC (979K shares), Kent Lake PR LLC (926K shares), and Vestal Point Capital, LP (830K shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.